HERSHBERG ROBERT — SEC insider filings

SEC reporting owner CIK 1274139. 57 insider filings on record with FilingPulse; latest filed 2026-11-17.

Transaction summary — filings shown

Covers the 50 most recent of 57 filings on record, filed 2020-11-18 to 2026-11-17. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Adaptive Biotechnologies Corp (ADPT)Director15—13 legs · 118,632 sh · $2,167,46527
AtaiBeckley Inc. (ATAI)Director3—1 leg · 100,000 sh · $496,00010
NanoString Technologies Inc (NSTG)Director7—18 legs · 5,832 sh · $419,44515
HilleVax, Inc. (HLVX)President and CEO, Director4—3 legs · 38,132 sh · $221,8225
RECURSION PHARMACEUTICALS, INC. (RXRX)Director11—1 leg · 25,000 sh · $125,00022
FATE THERAPEUTICS INC (FATE)Director4—1 leg · 672 sh · $15,2885
Atai Beckley N.V. (ATAI)Director1——4
Silverback Therapeutics, Inc. (SBTX)Director3——3
DANAHER CORP /DE/ (DHR)Director2——2

Insider filings — HERSHBERG ROBERT

FiledFormIssuerReported transactionsSource
2026-11-174DANAHER CORP /DE/ (DHR)Grant/award (A): 282 @ $0 · Grant/award (A): 663 (derivative) @ $0EDGAR
2026-10-163DANAHER CORP /DE/ (DHR)Holdings only — no transactions reportedEDGAR
2026-10-074RECURSION PHARMACEUTICALS, INC. (RXRX)Option exercise (M): 25,000 @ $2.22 · Sale (S): 25,000 @ $5 · Option exercise (M): 25,000 (derivative) @ $2.22EDGAR
2026-09-114AtaiBeckley Inc. (ATAI)Disposition to issuer (D): 48,858 (derivative) · Disposition to issuer (D): 404,869 (derivative) · Disposition to issuer (D): 62,394 (derivative) · Disposition to issuer (D): 103,000 (derivative) · Disposition to issuer (D): 121,968 (derivative)EDGAR
2026-08-204Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 15,000 @ $6.32 · Sale (S): 15,000 @ $24.39 · Sale (S): 15,664 @ $24.41 · Option exercise (M): 15,000 (derivative) @ $0EDGAR
2026-07-094AtaiBeckley Inc. (ATAI)Option exercise (M): 48,858 @ $1.35 · Option exercise (M): 51,142 @ $1.35 · Sale (S): 100,000 @ $4.96 · Option exercise (M): 48,858 (derivative) @ $0 · Option exercise (M): 51,142 (derivative) @ $0EDGAR
2026-06-224RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 88,424 @ $0EDGAR
2026-06-084AtaiBeckley Inc. (ATAI)Grant/award (A): 121,968 (derivative) @ $0EDGAR
2026-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 15,625 @ $0EDGAR
2025-12-124Adaptive Biotechnologies Corp (ADPT)Sale (S): 22,968 @ $16EDGAR
2025-11-064Atai Beckley N.V. (ATAI)Grant/award (A): 456,011 (derivative) @ $0 · Grant/award (A): 97,716 (derivative) @ $0 · Grant/award (A): 62,394 (derivative) @ $0 · Grant/award (A): 103,000 (derivative) @ $0EDGAR
2025-09-174HilleVax, Inc. (HLVX)Code (U): 1,101,498EDGAR
2025-06-234RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 22,016 @ $0 · Grant/award (A): 44,031 (derivative) @ $0EDGAR
2025-03-124Adaptive Biotechnologies Corp (ADPT)Sale (S): 53,000 @ $7.59EDGAR
2025-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 15,394 @ $0 · Grant/award (A): 23,726 (derivative) @ $0EDGAR
2025-02-124HilleVax, Inc. (HLVX)Sale (S): 14,634 @ $1.89 · Sale (S): 11,901 @ $1.76EDGAR
2024-06-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 13,097 @ $0 · Grant/award (A): 26,193 (derivative) @ $0EDGAR
2024-03-064Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 31,328 @ $0 · Grant/award (A): 48,044 (derivative) @ $0EDGAR
2024-02-124HilleVax, Inc. (HLVX)Sale (S): 11,597 @ $14.93 · Grant/award (A): 174,202 @ $0 · Grant/award (A): 226,885 (derivative) @ $0EDGAR
2023-06-214RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 12,612 @ $0 · Grant/award (A): 25,224 (derivative) @ $0EDGAR
2023-06-074FATE THERAPEUTICS INC (FATE)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2023-03-084Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 14,775 @ $0 · Grant/award (A): 23,329 (derivative) @ $0EDGAR
2023-02-034HilleVax, Inc. (HLVX)Grant/award (A): 187,966 @ $0 · Grant/award (A): 381,950 (derivative) @ $0EDGAR
2023-02-034Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 53,000 @ $0.45 · Option exercise (M): 53,000 (derivative) @ $0EDGAR
2022-06-164RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 18,145 @ $0 · Grant/award (A): 36,290 (derivative) @ $0EDGAR
2022-06-134FATE THERAPEUTICS INC (FATE)Grant/award (A): 8,650 @ $0 · Grant/award (A): 11,893 (derivative) @ $0EDGAR
2022-06-134Silverback Therapeutics, Inc. (SBTX)Grant/award (A): 18,000 (derivative) @ $0EDGAR
2022-06-064FATE THERAPEUTICS INC (FATE)Sale (S): 672 @ $22.75EDGAR
2022-04-184NanoString Technologies Inc (NSTG)Option exercise (M): 3,306 · Option exercise (M): 3,306 (derivative) @ $0EDGAR
2022-01-284Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 6,689 @ $0 · Grant/award (A): 16,722 (derivative) @ $0EDGAR
2022-01-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 693 @ $0EDGAR
2021-10-054RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 572 @ $0EDGAR
2021-09-214Silverback Therapeutics, Inc. (SBTX)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-07-064RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 347 @ $0EDGAR
2021-06-174NanoString Technologies Inc (NSTG)Option exercise (M): 5,520 · Option exercise (M): 5,520 (derivative) @ $0 · Grant/award (A): 3,890 (derivative) @ $0EDGAR
2021-06-044FATE THERAPEUTICS INC (FATE)Grant/award (A): 2,681 @ $0 · Grant/award (A): 4,334 (derivative) @ $0EDGAR
2021-04-224RECURSION PHARMACEUTICALS, INC. (RXRX)Conversion (C): 6,250 @ $0 · Conversion (C): 6,250 @ $0 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 12,500 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0 · Conversion (C): 525,000 (derivative) @ $0EDGAR
2021-04-194RECURSION PHARMACEUTICALS, INC. (RXRX)Grant/award (A): 6,250 @ $0 · Grant/award (A): 12,500 (derivative) @ $0EDGAR
2021-04-194NanoString Technologies Inc (NSTG)Option exercise (M): 144 @ $14.71 · Sale (S): 7 @ $71.75 · Sale (S): 19 @ $72.87 · Sale (S): 118 @ $74.20 · Option exercise (M): 144 (derivative) @ $14.71EDGAR
2021-03-174NanoString Technologies Inc (NSTG)Option exercise (M): 1,500 @ $11.20 · Sale (S): 4 @ $63.58 · Sale (S): 282 @ $66.03 · Sale (S): 1,214 @ $67.16 · Option exercise (M): 1,500 (derivative) @ $0EDGAR
2021-03-104Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $44.56 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2021-03-104Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $44.56 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2021-02-184NanoString Technologies Inc (NSTG)Option exercise (M): 1,188 @ $11.20 · Sale (S): 318 @ $78.40 · Sale (S): 323 @ $79.53 · Sale (S): 159 @ $80.55 · Sale (S): 156 @ $81.79 · Sale (S): 163 @ $82.83 · +2 moreEDGAR
2021-02-174Adaptive Biotechnologies Corp (ADPT)Grant/award (A): 1,504 @ $0 · Option exercise (M): 2,000 @ $0.45 · Sale (S): 2,000 @ $65.45 · Grant/award (A): 3,759 (derivative) @ $0 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2021-01-204Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,378 @ $66.34 · Sale (S): 622 @ $67.05 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2021-01-194NanoString Technologies Inc (NSTG)Option exercise (M): 1,500 @ $11.20 · Sale (S): 709 @ $71.77 · Sale (S): 410 @ $72.91 · Sale (S): 291 @ $73.66 · Sale (S): 90 @ $74.55 · Option exercise (M): 1,500 (derivative) @ $11.20EDGAR
2020-12-164Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,759 @ $55.78 · Sale (S): 241 @ $57.01 · Option exercise (M): 2,000 (derivative) @ $0EDGAR
2020-12-164NanoString Technologies Inc (NSTG)Option exercise (M): 1,500 @ $11.20 · Sale (S): 688 @ $68.68 · Sale (S): 812 @ $69.88 · Option exercise (M): 1,500 (derivative) @ $11.20EDGAR
2020-12-074Silverback Therapeutics, Inc. (SBTX)Grant/award (A): 73,251 (derivative) @ $0EDGAR
2020-11-184Adaptive Biotechnologies Corp (ADPT)Option exercise (M): 2,000 @ $0.45 · Sale (S): 1,777 @ $47.60 · Sale (S): 223 @ $48.41 · Option exercise (M): 2,000 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-18 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1274139 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs